Fusion Antibodies
10 results

Fusion Antibodies sees revenue continue to grow
- Health & Pharma
- October 22, 2019, 07:46
Fusion Antibodies, a pharmaceutical contract research company with its headquarters in Belfast, said revenue continued to grow in the six months to th(...)

Fusion Antibodies sees full year revenues dip 19%
- Health & Pharma
- July 2, 2019, 10:56
Northern Ireland contract research company Fusion Antibodies recorded a 19 per cent fall in full year revenues to £2.2 million on the back of a weak f(...)

Fusion Antibodies confirms second-half pick-up in revenue
- Health & Pharma
- April 17, 2019, 09:15
Belfast-based Fusion Antibodies said its performance in the second half of the year ended March 31st improved as orders and revenues significantly inc(...)

Fusion Antibodies warns of weaker revenues for 2019
- Health & Pharma
- February 25, 2019, 09:27
Northern Ireland contract research company Fusion Antibodies warned that revenues for the year ended March 31st would be “materially below current mar(...)

Losses at Fusion Antibodies quadruple in ‘challenging’ period
- Health & Pharma
- November 26, 2018, 09:46
Losses at Belfast pharmaceutical company Fusion Antibodies quadrupled in the six months ended September 30th compared with the same period last year, (...)

Fusion Antibodies reports £700,000 loss for first trading year
- Health & Pharma
- August 16, 2018, 10:46
Fusion Antibodies, the Northern Ireland contract research company, has reported losses of nearly £700,000 (€781,000) for its maiden year as an AIM-lis(...)

Shares dive in NI-based clinical trials group
- Health & Pharma
- August 13, 2018, 11:29
Fusion Antibodies, the Belfast-based contract research organisation, has issued a profit warning after it disclosed that trading for the current finan(...)

Fusion Antibodies flags full year revenues behind expectations
- Health & Pharma
- March 5, 2018, 14:11
Belfast pharmaceutical company Fusion Antibodies said it expects revenues for the trading year ended March 31st 2018 to grow at least 40 per cent on t(...)

Fusion Antibodies raises £5.5m in London Stock Exchange debut
- Health & Pharma
- December 18, 2017, 17:17
Belfast pharma company Fusion Antibodies has raised £5.5 million (€6.2m) in its debut on the junior market of the London Stock Exchange. Fusion, a c(...)

Innovation finalists: making a difference in medical industry
- Business
- March 9, 2015, 01:00
Embo Medical Embo Medical has created a new medical device which makes embolization procedures faster and less expensive while also offering mo(...)